Sopharma AD (SPH) — Long-term Investment Intensity
Sopharma AD (SPH) has a Long-term Investment Intensity of 0.0% as of September 2022. Long-term investments of zł168.00 represent 0.0% of total assets of zł1.25 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Sopharma AD (SPH) shareholders funds for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sopharma AD Long-term Investment Intensity (2017–2021)
This chart shows how Sopharma AD's Long-term Investment Intensity has evolved across 5 annual periods from 2017 to 2021. As of September 2022, the intensity stands at 0.0%, reflecting long-term investments of zł168.00 against total assets of zł1.25 Billion PLN. Also explore Sopharma AD balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Sopharma AD (2017–2021)
The table below presents the year-by-year Long-term Investment Intensity for Sopharma AD from 2017 to 2021, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Sopharma AD market cap and net worth.
| Year | LT Investment Intensity | LT Investments (PLN) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.0% | zł143.00 | zł1.20 Billion | ▼ 0.0 pp |
| 2020 | 0.0% | zł149.00 | zł1.24 Billion | ▼ 0.0 pp |
| 2019 | 0.0% | zł176.00 | zł1.18 Billion | ▲ +0.0 pp |
| 2018 | 0.0% | zł62.00 | zł1.01 Billion | ▲ +0.0 pp |
| 2017 | 0.0% | zł58.00 | zł980.73 Million | — |